Consultant in paediatric infectious diseases, St George's University Hospitals NHS Foundation Trust

Professor Mike Sharland is a leading expert in antimicrobial prescribing, resistance and healthcare associated infection in children. He is the lead clinical advisor for the neonatal and paediatric programme of the Global Antibiotic Research and Development Partnership (GARDP) and Vice-Chair and AMR lead of the Penta Foundation, a global Paediatric Infectious Diseases research network.

He previously Chaired the Department of Health’s Expert Advisory Committee of Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (APRHAI). He has been an advisor for the WHO for many years. He is member of the Expert Committee on the Selection and Use of Essential Medicines and Chair of the Antibiotic Working Group of the EML/EMLc, assisting with the development of the Access/Watch/Reserve (AWaRE) grouping of antibiotics and WHO global targets on use.
Prof Sharland’s principal research interest is optimising the use of antimicrobials in children. At St George’s University London he leads a major program of research including global cohort studies and clinical trials to improve the evidence base for antimicrobial prescribing.